The Sure Supply Program is designed to provide health systems with reliable access to medications at risk of shortage, offering a six-month safety stock reserve based on each health system’s purchasing commitments, according to a Feb. 6 news release from the company.
In 2023, over 99% of hospital and health system pharmacists reported drug shortages, driving an increase in demand for mitigation solutions. By negotiating long-term agreements with manufacturers to produce additional inventory, Cencora aims to stabilize the supply chain and reduce the strain on hospitals.
The expanded program covers a range of therapeutic areas, including oncology, critical care, cardiovascular and infectious diseases.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
